[New isoprenaline-derivative (1-(3,5-dihydroxyphenyl)-1-hydroxy-2-1(4-hydroxyphenyl)-isopropyl-aminoethane. Th 1165 a) in therapy of acute cardiovascular and respiratory emergencies].
D000208:Acute Disease; D000318:Adrenergic beta-Agonists; D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001249:Asthma / Q000188:drug therapy; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D004630:Emergencies; D005260:Female; D006323:Heart Arrest / Q000188:drug therapy; D006801:Humans; D008297:Male; D009921:Metaproterenol / Q000627:therapeutic use; D008875:Middle Aged; D010627:Phenethylamines / Q000627:therapeutic use; D012118:Resorcinols / Q000627:therapeutic use; D012131:Respiratory Insufficiency / Q000188:drug therapy*; D012769:Shock / Q000188:drug therapy; D013566:Sympathomimetics / Q000009:adverse effects / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use; D014693:Ventricular Fibrillation / Q000188:drug therapy
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D010627:Phenethylamines; D012118:Resorcinols; D013566:Sympathomimetics; D014665:Vasodilator Agents; D009921:Metaproterenol
Ein neues Isoprenalin-Derivat (1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-1-(4-hydroxyphenyl)-isopropyl-aminoaethan, Th 1165 a) in der Therapie akuter cardiovaskulärer und respiratorischer Notfallsituationen.